Literature DB >> 17768504

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi.

Joseph Kwong-Leung Yu1, Solomon Chih-Cheng Chen, Kuo-Yang Wang, Chao-Sung Chang, Simon D Makombe, Erik J Schouten, Anthony D Harries.   

Abstract

PROBLEM: In many resource-poor countries that are scaling up antiretroviral therapy (ART), 5-25% of patients are reported as "lost to follow-up". This figure is 9% in Malawi. There is no published information about the true outcome status of these patients. APPROACH: In four facilities in northern Malawi, ART registers and master cards were used to identify patients who had not attended the facility for 3 months or more and were thus registered as "lost to follow-up". Clinic staff attempted to trace these patients and ascertain their true outcome status. LOCAL
SETTING: Of 253 patients identified as "lost to follow-up", 127 (50%) were dead, 58% of these having died within 3 months of their last clinic visit. Of the 58 patients (23%) found to be alive, 21 were still receiving ART and 37 had stopped treatment (high transport costs being the main reason for 13 patients). Sixty-eight patients (27%) could not be traced, most commonly because of an incorrect address in the register. Fewer patients were alive and more patients could not be traced from the central hospital compared with the peripheral hospitals. RELEVANT CHANGES: Better documentation of patients addresses and prompt follow-up of patients who are late for their appointments are required. LESSONS LEARNED: ART clinics in resource-poor countries should ensure that patients addresses are correct and comprehensive. Clinics should also undertake contact tracing as soon as possible in the event of non-attendance, consider facilitating access to ART clinics and take loss to follow-up into consideration when assessing death rates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768504      PMCID: PMC2636367          DOI: 10.2471/blt.06.037739

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Authors:  Laurent Ferradini; Arnaud Jeannin; Loretxu Pinoges; Jacques Izopet; Didakus Odhiambo; Limangeni Mankhambo; Gloria Karungi; Elisabeth Szumilin; Serge Balandine; Gaëlle Fedida; M Patrizia Carrieri; Bruno Spire; Nathan Ford; Jean-Michel Tassie; Philippe J Guerin; Chris Brasher
Journal:  Lancet       Date:  2006-04-22       Impact factor: 79.321

2.  Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.

Authors:  E Libamba; S Makombe; A D Harries; R Chimzizi; F M Salaniponi; E J Schouten; R Mpazanje
Journal:  Int J Tuberc Lung Dis       Date:  2005-10       Impact factor: 2.373

3.  Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

Authors:  Kara Wools-Kaloustian; Silvester Kimaiyo; Lameck Diero; Abraham Siika; John Sidle; Constantin T Yiannoutsos; Beverly Musick; Robert Einterz; Kenneth H Fife; William M Tierney
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

4.  True status of smear-positive pulmonary tuberculosis defaulters in Malawi.

Authors:  M L Kruyt; N D Kruyt; M J Boeree; A D Harries; F M Salaniponi; P A van Noord
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

5.  Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.

Authors:  C William Wester; Soyeon Kim; Hermann Bussmann; Ava Avalos; Ndwapi Ndwapi; Trevor F Peter; Tendani Gaolathe; Andrew Mujugira; Lesego Busang; Chris Vanderwarker; Peter Cardiello; Onalethata Johnson; Ibou Thior; Patson Mazonde; Howard Moffat; Max Essex; Richard Marlink
Journal:  J Acquir Immune Defic Syndr       Date:  2005-11-01       Impact factor: 3.731

6.  Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.

Authors:  Alexandra Calmy; Lorextu Pinoges; Elisabeth Szumilin; Rony Zachariah; Nathan Ford; Laurent Ferradini
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

7.  Antiretroviral therapy in a thousand patients with AIDS in Haiti.

Authors:  Patrice Severe; Paul Leger; Macarthur Charles; Francine Noel; Gerry Bonhomme; Gyrlande Bois; Erik George; Stefan Kenel-Pierre; Peter F Wright; Roy Gulick; Warren D Johnson; Jean William Pape; Daniel W Fitzgerald
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

8.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Authors:  Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

  8 in total
  128 in total

1.  A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.

Authors:  Nellie Wadonda-Kabondo; Bethany L Hedt; Joep J van Oosterhout; Kundai Moyo; Eddie Limbambala; George Bello; Ben Chilima; Erik Schouten; Anthony Harries; Moses Massaquoi; Carol Porter; Ralf Weigel; Mina Hosseinipour; John Aberle-Grasse; Michael R Jordan; Storn Kabuluzi; Diane E Bennett
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

2.  Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?

Authors:  A Boulle; N Ford
Journal:  Sex Transm Infect       Date:  2007-12       Impact factor: 3.519

3.  Mortality patterns among adult women in Malawi, 1979-2004.

Authors:  Adamson S Muula
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

4.  Retention and loss to follow-up in antiretroviral treatment programmes in southeast Nigeria.

Authors:  C A Onoka; B S Uzochukwu; O E Onwujekwe; C Chukwuka; J Ilozumba; C Onyedum; E A Nwobi; C Onwasigwe
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

5.  Risk factors for mortality in Malawian children with human immunodeficiency virus and tuberculosis co-infection.

Authors:  W C Buck; D Olson; M M Kabue; S Ahmed; L K Nchama; A Munthali; M C Hosseinipour; P N Kazembe
Journal:  Int J Tuberc Lung Dis       Date:  2013-11       Impact factor: 2.373

6.  Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi.

Authors:  Bradley C Fetzer; Mina C Hosseinipour; Portia Kamthuzi; Lisa Hyde; Brian Bramson; Kebba Jobarteh; Kristine Torjesen; William C Miller; Irving Hoffman; Peter Kazembe; Charles Mwansambo
Journal:  Trop Med Int Health       Date:  2009-06-28       Impact factor: 2.622

7.  Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.

Authors:  Benjamin H Chi; Albert Mwango; Mark Giganti; Lloyd B Mulenga; Bushimbwa Tambatamba-Chapula; Stewart E Reid; Carolyn Bolton-Moore; Namwinga Chintu; Priscilla L Mulenga; Elizabeth M Stringer; Robert Sheneberger; Peter Mwaba; Jeffrey S A Stringer
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

8.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Authors:  Martin W G Brinkhof; François Dabis; Landon Myer; David R Bangsberg; Andrew Boulle; Denis Nash; Mauro Schechter; Christian Laurent; Olivia Keiser; Margaret May; Eduardo Sprinz; Matthias Egger; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

9.  Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique.

Authors:  Tom Decroo; Isabella Panunzi; Carla das Dores; Fernando Maldonado; Marc Biot; Nathan Ford; Kathryn Chu
Journal:  J Int AIDS Soc       Date:  2009-05-06       Impact factor: 5.396

10.  Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Authors:  Elena Losina; Hapsatou Touré; Lauren M Uhler; Xavier Anglaret; A David Paltiel; Eric Balestre; Rochelle P Walensky; Eugène Messou; Milton C Weinstein; François Dabis; Kenneth A Freedberg
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.